Back
Kimberly - Clark de Mexico SAB de CV Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
29
KCDMY
Kimberly - Clark de Mexico SAB de CV
Last Price:
7.26
Seasonality Move:
3.03%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
54.85
Seasonality Move:
12.42%
Sell
29
Kimberly - Clark de Mexico SAB de CV (KCDMY)
is a Sell
Is Kimberly - Clark de Mexico SAB de CV a Buy, Sell or Hold?
- The current Kimberly - Clark de Mexico SAB de CV [KCDMY] share price is $7.26. The Score for KCDMY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- KCDMY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $54.79. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KCDMY Stock Price Chart
What is Kimberly - Clark de Mexico SAB de CV's stock price today?
-
The Kimberly - Clark de Mexico SAB de CV share price today is $7.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KCDMY is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $54.79
The current trend is moderately bearish and RARE is experiencing slight buying pressure.
KCDMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 31.92 | Sell |
Chaikin Money Flow: | -47698 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.73 - 8.31) | Sell |
Bollinger Bands (100): | (8.05 - 9.25) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 47.17 | Sell |
Chaikin Money Flow: | 157903 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.97 - 57.61) | Sell |
Bollinger Bands (100): | (42.49 - 56.25) | Buy |
KCDMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.7 | Sell |
20-day SMA: | 7.96 | Sell |
50-day SMA: | 8.27 | Sell |
200-day SMA: | 9.88 | Sell |
8-day EMA: | 7.65 | Sell |
20-day EMA: | 7.89 | Sell |
50-day EMA: | 8.23 | Sell |
200-day EMA: | 9.35 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.68 | Sell |
20-day SMA: | 55.18 | Sell |
50-day SMA: | 55.69 | Sell |
200-day SMA: | 47.54 | Buy |
8-day EMA: | 55.4 | Sell |
20-day EMA: | 55.43 | Sell |
50-day EMA: | 54.18 | Buy |
200-day EMA: | 48.46 | Buy |
Kimberly - Clark de Mexico SAB de CV Earnings Growth & KCDMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.
Kimberly - Clark de Mexico SAB de CV Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |